Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Questions about the 10 x '20 Initiative.
Outterson K, Powers JH 3rd, Gould IM, Kesselheim AS. Outterson K, et al. Clin Infect Dis. 2010 Sep 15;51(6):751-2; author reply 754-5. doi: 10.1086/655955. Clin Infect Dis. 2010. PMID: 20731566 No abstract available.
Improving antibiotic markets for long-term sustainability.
Kesselheim AS, Outterson K. Kesselheim AS, et al. Among authors: outterson k. Yale J Health Policy Law Ethics. 2011 Winter;11(1):101-67. Yale J Health Policy Law Ethics. 2011. PMID: 21381513 No abstract available.
A shot in the arm for new antibiotics.
Outterson K. Outterson K. Nat Biotechnol. 2019 Oct;37(10):1110-1112. doi: 10.1038/s41587-019-0279-8. Nat Biotechnol. 2019. PMID: 31578512 No abstract available.
Antibiotic research and development: business as usual?
Harbarth S, Theuretzbacher U, Hackett J; DRIVE-AB consortium. Harbarth S, et al. J Antimicrob Chemother. 2015;70(6):1604-7. doi: 10.1093/jac/dkv020. Epub 2015 Feb 10. J Antimicrob Chemother. 2015. PMID: 25673635
International cooperation to improve access to and sustain effectiveness of antimicrobials.
Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Smith R, Zorzet A, Cohn J, Pittet D, Daulaire N, Morel C, Rizvi Z, Balasegaram M, Dar OA, Heymann DL, Holmes AH, Moore LS, Laxminarayan R, Mendelson M, Røttingen JA. Årdal C, et al. Among authors: outterson k. Lancet. 2016 Jan 16;387(10015):296-307. doi: 10.1016/S0140-6736(15)00470-5. Epub 2015 Nov 18. Lancet. 2016. PMID: 26603920 Review.
Market watch: Innovation in the preclinical antibiotic pipeline.
Theuretzbacher U, Savic M, Årdal C, Outterson K. Theuretzbacher U, et al. Among authors: outterson k. Nat Rev Drug Discov. 2017 Nov;16(11):744-745. doi: 10.1038/nrd.2017.195. Epub 2017 Oct 6. Nat Rev Drug Discov. 2017. PMID: 28983100 No abstract available.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Among authors: outterson k. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
68 results